Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls Trial Phase 1 Completed June 3, 2014
Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a Trial Phase 1 Completed June 3, 2014
Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease Trial N/A Unknown June 2, 2014
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease Trial Phase 3 Completed June 2, 2014
Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals for Healthy Controls Evoked Response Potential (ERP) Signals for Healthy Controls and Patients With Parkinson Disease Trial N/A Unknown May 28, 2014
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease Trial Phase 2 Completed May 27, 2014
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients Trial Phase 3 Completed May 22, 2014
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Trial Phase 2 Completed May 22, 2014
Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment Trial N/A Completed May 19, 2014
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Trial Phase 3 Completed May 19, 2014
Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease Trial Phase 3 Completed May 15, 2014
Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) Trial Phase 4 Completed May 15, 2014
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Trial Phase 3 Completed May 15, 2014
a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients Trial N/A Completed May 15, 2014
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients Trial Phase 4 Completed May 15, 2014
Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD Trial Phase 3 Completed May 15, 2014
Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms Trial Phase 4 Completed May 8, 2014
Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial Trial Phase 3 Completed May 8, 2014